Table 3.
The Percentage of Patients with HbA1c Value Less than 7.0%/Less than 8.0%.
| Years | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | p for trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Age group | ||||||||||
| <65 | ||||||||||
| All category | 24.0%/58.8% | 28.9%/65.0% | 38.5%/71.2% | 42.1%/74.2% | 44.0%/76.3% | 39.8%/77.5% | 41.4%/77.7% | 48.5%/80.2% | 48.3%/81.2% | <0.001/<0.001 |
| Category A | 56.0%/88.7% | 54.9%/88.8% | 63.4%/88.4% | 67.2%/91.4% | 68.7%/92.7% | 67.8%/94.6% | 70.7%/95.0% | 80.5%/96.6% | 81.0%/98.8% | <0.001/<0.001 |
| Category B-1 | 28.5%/66.6% | 38.5%/74.4% | 48.3%/81.4% | 47.9%/79.0% | 51.5%/86.3% | 46.4%/85.6% | 47.7%/84.7% | 55.6%/87.4% | 58.0%/88.9% | <0.001/<0.001 |
| Category B-2 | 18.0%/56.5% | 22.4%/62.6% | 30.4%/68.2% | 33.7%/70.8% | 35.3%/71.7% | 41.4%/80.7% | 31.6%/72.9% | 38.3%/75.6% | 36.2%/77.1% | <0.001/<0.001 |
| Category C | 13.0%/39.5% | 14.3%/41.6% | 22.8%/50.6% | 26.4%/57.2% | 28.3%/56.6% | 41.9%/82.2% | 22.4%/58.7% | 29.2%/62.2% | 27.3%/61.0% | <0.001/<0.001 |
| 65-75 | ||||||||||
| All category | 27.3%/67.4% | 32.2%/69.8% | 36.2%/75.2% | 40.0%/76.8% | 43.4%/80.4% | 40.1%/81.3% | 41.1%/81.2% | 49.8%/85.2% | 54.2%/86.9% | <0.001/<0.001 |
| Category A | 48.6%/86.3% | 52.1%/93.3% | 60.2%/93.4% | 60.2%/93.0% | 65.5%/92.4% | 62.6%/94.8% | 67.5%/94.8% | 81.8%/97.4% | 79.5%/98.0% | <0.001/0.007 |
| Category B-1 | 40.3%/81.5% | 44.7%/83.0% | 50.5%/87.2% | 58.1%/86.9% | 60.5%/91.0% | 54.3%/92.7% | 53.5%/89.6% | 62.4%/60.6% | 68.2%/94.7% | <0.001/<0.001 |
| Category B-2 | 23.0%/66.9% | 27.9%/68.0% | 31.4%/73.4% | 34.8%/77.0% | 37.7%/80.2% | 41.8%/80.0% | 33.6%/80.4% | 43.6%/83.8% | 45.2%/85.0% | <0.001/<0.001 |
| Category C | 17.6%/48.8% | 23.4%/53.4% | 24.7%/61.7% | 27.4%/60.5% | 30.4%/66.7% | 39.2%/79.6% | 26.5%/65.7% | 30.8%/69.8% | 38.2%/74.3% | <0.001/<0.001 |
| ≥ 75 | ||||||||||
| All category | 31.5%/70.2% | 35.7%/70.7% | 39.5%/76.8% | 43.4%/78.7% | 47.8%/83.4% | 40.3%/82.4% | 42.2%/80.5% | 46.1%/83.7% | 50.7%/86.0% | <0.001/<0.001 |
| Category A | 49.2%/86.4% | 61.9%/90.5% | 62.9%/95.5% | 59.8%/91.6% | 64.2%/96.7% | 63.0%/95.2% | 71.9%/91.1% | 71.3%/97.1% | 82.5%/95.8% | <0.001/0.023 |
| Category B-1 | 51.3%/86.5% | 46.7%/82.2% | 55.4%/90.5% | 57.1%/93.8% | 68.2%/95.3% | 60.3%/90.4% | 56.5%/92.5% | 60.6%/95.3% | 67.0%/94.2% | 0.013/0.011 |
| Category B-2 | 28.5%/68.4% | 31.1%/69.5% | 35.8%/75.2% | 41.3%/78.2% | 44.3%/82.8% | 37.3%/80.3% | 35.3%/77.8% | 43.0%/83.7% | 45.2%/85.3% | <0.001/<0.001 |
| Category C | 21.5%/59.8% | 28.0%/58.7% | 30.4%/66.5% | 33.8%/66.2% | 36.7%/72.3% | 41.2%/84.2% | 30.4%/72.2% | 30.8%/70.4% | 33.2%/76.0% | 0.19/<0.001 |
Category A: not prescribed any antidiabetic drugs, category B-1: prescribed antidiabetic drugs other than sulfonylureas or glinides, category B-2: prescribed sulfonylureas or glinides, category C: prescribed insulin